| Displacement of [3H]DPDPE from delta opioid receptor in dog brain after 90 mins by scintillation counting - BioAssay Summary 3-Azabicyclo[3.1.0]hexane compounds were designed as novel achiral ## opioid receptor ligands for the treatment of pruritus in dogs. In this paper, we describe the SAR of this class of opioid ligand, highlighting changes to the lead structure which led to compounds having picomolar binding affinity, selective for the ## receptor over ## and ## subtypes. Some subtleties of functional activity will also be described. ..more |
_ | |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
BioActive Compounds: 12 Description: Title: SAR and biological evaluation of 3-azabicyclo[3.1.0]hexane derivatives as ## opioid ligands. Abstract: 3-Azabicyclo[3.1.0]hexane compounds were designed as novel achiral ## opioid receptor ligands for the treatment of pruritus in dogs. In this paper, we describe the SAR of this class of opioid ligand, highlighting changes to the lead structure which led to compounds having picomolar binding affinity, selective for the ## receptor over ## and ## subtypes. Some subtleties of functional activity will also be described. (PMID: 22357342) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Putative Target: ChEMBL Target ID: 22226 Target Type: UNCHECKED Pref Name: Unchecked Confidence: Default value - Target unknown or has yet to be assigned Relationship Type: Default value - Target has yet to be curated Categorized Comment ChEMBL Assay Type: Binding ChEMBL Assay Data Source: Scientific Literature Result Definitions
* Activity Concentration. Data Table (Concise)
PageFrom: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||